Skip to main content
Sunshine Biopharma Inc. logo

Sunshine Biopharma Inc. — Investor Relations & Filings

Ticker · SBFM ISIN · US8677817004 LEI · 5299005Y64EHRQDQ2Q25 US Manufacturing
Open in API
Filings indexed 382 across all filing types
Latest filing 2007-12-14 Interim / Quarterly Rep…
Country US United States of America
Listing US SBFM

About Sunshine Biopharma Inc.

https://www.sunshinebiopharma.com/

Sunshine Biopharma Inc. is a pharmaceutical company engaged in the research, development, and commercialization of life-saving medicines. The company's primary focus is on various therapeutic areas, with a significant emphasis on oncology and antiviral treatments.

Recent filings

Filing Released Lang Actions
10-QSB FIRST QUARTER 10-31-2007
Interim / Quarterly Report Classification · 100% confidence The document is titled 'FORM 10-QSB' and is a quarterly report pursuant to the Securities Exchange Act of 1934 for the quarterly period ended October 31, 2007. It contains unaudited financial statements including balance sheet, statements of operations, shareholders' equity, cash flows, and notes to the financial statements. It also includes Management's Discussion and Analysis (MD&A) and other required disclosures for a quarterly period. The document length is 15,000 characters, indicating it is a full report rather than a brief announcement. The presence of detailed financial data and MD&A confirms it is a comprehensive interim financial report. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2007-12-14 English
REPORT 10-KSB
Annual Report Classification · 100% confidence The document is titled 'FORM 10-KSB' and is described as an 'Annual Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934' for the fiscal year ended July 31, 2007. It contains detailed sections typical of an annual report, including business description, risk factors, management discussion and analysis, financial statements, legal proceedings, executive compensation, and other comprehensive disclosures. The length of the document (15,000 characters) and the presence of substantive financial and operational information confirm it is the full annual report, not just an announcement or summary. Therefore, this document fits the definition of an Annual Report (10-K).
2007-11-13 English
FORM 8A12G
Regulatory Filings Classification · 95% confidence The document is a Form 8-A filed with the SEC, which is used for the registration of certain classes of securities pursuant to Section 12(b) or 12(g) of the Securities Exchange Act of 1934. It includes details about the registrant, the securities to be registered, and references to other filings incorporated by reference. The document is not a financial report, earnings release, or management discussion, but rather a regulatory filing related to securities registration. Given the nature and content, it fits best under Regulatory Filings (RNS). The document length is short and it is a formal SEC filing, not an announcement or a report publication notice.
2007-11-07 English
PROSPECTUS
Capital/Financing Update Classification · 100% confidence The document is a prospectus for the offering of common stock by Mountain West Business Solutions, Inc. It includes detailed information about the offering, risk factors, use of proceeds, management discussion, and financial statements. The document is not an annual report, earnings release, or any other financial report but rather a registration and offering document related to securities issuance. The presence of terms like 'prospectus', 'offering', 'selling stockholders', 'plan of distribution', and detailed risk disclosures indicates this is a capital/financing update document. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and content confirm it is not a brief announcement or a regulatory filing but a full prospectus.
2007-11-06 English
Regulatory Filings 2007
Regulatory Filings
2007-11-06 English
SB-2
Capital/Financing Update Classification · 95% confidence The document is a Form SB-2 Registration Statement filed with the SEC, which is a registration statement under the Securities Act of 1933. It includes a prospectus for the offering of common stock by selling stockholders. The document contains detailed information about the company, the offering, risk factors, management discussion, and financial statements. This type of filing is related to capital raising and securities registration rather than a financial report, earnings release, or management discussion. The document is not an announcement or a brief summary but a full registration statement with a prospectus. Therefore, it fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2007-10-19 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.